Ceasefire agreed after death of Palestinian hunger striker in Israeli custody sparks fighting

By Nidal al-Mughrabi and Henriette Chacar JERUSALEM/GAZA (Reuters) -A Palestinian hunger striker died in Israeli custody on Tuesday, sparking an exchange of fire between Israel and armed groups in Gaza, before three Palestinian officials said the sides had agreed to a ceasefire. Earlier, Israeli jets struck in Gaza as armed groups there fired rocket barrages…

Read More

Aston Martin sticks to 2023 outlook after smaller Q1 pretax loss

(Reuters) -British luxury carmaker Aston Martin Lagonda on Wednesday reported a narrower quarterly pretax loss and maintained its 2023 outlook, benefiting from the strong sales of its sport utility vehicle DBX and higher selling prices. Aston Martin, whose models were favoured by fictional British spy James Bond, had said in March that it expects profitability…

Read More

UniCredit raises 2023 goals after stronger than expected quarter

MILAN (Reuters) – UniCredit on Wednesday raised its financial targets for the year, after posting much stronger than expected first quarter earnings. Solid results by Italy’s only bank that regulators deem of global systemic relevance are the latest evidence of strength for a sector where a string of failures this year has shaken investors’ confidence….

Read More

Global rate hike push slows to a trickle in April ahead of busy May

By Karin Strohecker and Vincent Flasseur LONDON (Reuters) – Interest rate hikes from central banks around the globe slowed to a trickle in April thanks to a combination of easing inflation and slowing growth prospects amid a dearth of meetings on monetary policy decisions. April saw two interest rate hikes across five meetings by central…

Read More

Analysis-Investors see big Novo Nordisk stock boost if obesity drug shows heart benefit

By Maggie Fick LONDON (Reuters) – Positive trial data showing Novo Nordisk’s obesity drug helps save and extend lives, not just lose weight, could propel Europe’s best-performing stock even higher, according to 10 investors and industry analysts interviewed by Reuters. Demand for the Danish company’s weight-loss treatment Wegovy is soaring in the United States, leading…

Read More